# Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+

> **NCT01174914** · PHASE2 · COMPLETED · sponsor: **The Ojai Foundation** · enrollment: 171 (actual)

## Conditions studied

- HIV Seropositivity

## Interventions

- **OTHER:** ARV's + Placebo
- **DRUG:** Naltrexone
- **DRUG:** Naltrexone + ARV's

## Key facts

- **NCT ID:** NCT01174914
- **Lead sponsor:** The Ojai Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 171 (ACTUAL)
- **Last updated:** 2010-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01174914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01174914, "Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01174914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*